01 January 1999
Low-dose aspirin and serum lipoprotein(a) concentrations in patients with EPH-gestosis
Franciszek Kokot, Christian Wanner, Violetta Ciszek, Edward FranekMed Sci Monit 1999; 5(1): CR55-57 :: ID: 505214
Abstract
Introduction: Lipoprotein(a) due to its thrombogenic properties, probably plays an important role in EPHgestosis vascular injury patients. Aspirin may influence the relationship between lp(a) and vascular pathology.Material and methods: This study assessed serum Lp(a) levels in 45 healthy pregnant women (HPW), 27 women with mild or moderate gestosis and in 30 non-pregnant women. Gestosis patients comprised 10 women treated with low-dose aspirin (0.15 g/day) during the last three months of pregnancy (Asp-EPH group) and 17 women who did not receive the drug (Non-Asp-EPH group). In EPH-gestosis subjects, Lp(a) concentrations were assessed (by means of a nephelometric immunoassay method) from blood samples withdrawn three months before delivery and at the day of the expected delivery, while in HPW only during the day of expected delivery. Results: Serum Lp(a) concentration levels at term of expected delivery were of similar magnitude in HPW, Asp-EPH and Non-Asp-EPH patients (27.3±4.4 vs. 39.8±14.1 vs. 26.3±4.6 mg/dl). Although these values exceeded those of the control group (17.7±4.4 mg/dl) the difference was statistically insignificant (all values as mean±SEM). In Asp-EPH and Non-Asp-EPH women, serum Lp(a) concentrations did not change significantly during the last three months of pregnancy (from 29.3±10.4 to 39.8±14.1 and from 36.2±5.6 to 26.3±4.6 mg/dl, respectively). Conclusions: Pregnant women with mild or moderate gestosis demonstrate serum Lp(a) levels of similar magnitude as HPW. Low-dose aspirin treatment for three months does not significantly influence serum Lp(a) concentrations in EPH-gestosis patients.
Keywords: Lp(a), EPH-gestosis
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
15 Apr 2024 : Laboratory Research
The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in OsteoarthritisMed Sci Monit In Press; DOI: 10.12659/MSM.943738
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
08 Mar 2024 : Animal Research
Modification of Experimental Model of Necrotizing Enterocolitis (NEC) in Rat Pups by Single Exposure to Hyp...Med Sci Monit In Press; DOI: 10.12659/MSM.943443
18 Apr 2024 : Clinical Research
Comparative Analysis of Open and Closed Sphincterotomy for the Treatment of Chronic Anal Fissure: Safety an...Med Sci Monit In Press; DOI: 10.12659/MSM.944127
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952